CONTACT
+91 80 2808 2808
info@biocon.com

WHO WE ARE

Driven by purpose.

We are a global biopharmaceutical company with the belief that everyone, everywhere deserves access to affordable quality medicines.

MORE >>

WHO WE ARE

Driven by purpose.

We are a global biopharmaceutical company with the belief that everyone, everywhere deserves access to affordable quality medicines.

MORE >>

OUR BUSINESSES

Path-breaking offerings.
Far-reaching impact.

GENERICS


>>
...

BIOSIMILARS


>>
...

RESEARCH SERVICES


>>
...

NOVEL BIOLOGICS


>>
...

GLOBAL PRESENCE

0
+
Countries
0
+
Employees
0
+
Patents Granted
0
+
Registered Trademarks

NEWS

#SheInspires, The inspiring tales of our own Women In Science at Biocon Biologics.

Kiran Mazumdar-Shaw speaking on Biocon’s Q1 FY23 Earnings

MORE  >>
  

Insulin Glargine: Journey to the historic U.S. approval for the first interchangeable biosimilar

Biocon Biologics Global Scale Capabilities

Biocon annual report 2022

ANNUAL REPORT 2022

Metamorphosis: Biocon 5.0

VIEW  >>
Biocon ESG Report 2022

ESG REPORT 2022

Transform Action

View  >>
Governance

GOVERNANCE

Behind consistent growth is good governance.

MORE  >>

RESPONSIBILITY

Transforming
tomorrow.

Biocon is committed to address the world’s developmental challenges

RESPONSIBILITY

Transforming
tomorrow.

Biocon is committed to address the world’s developmental challenges

More  >>
Share
Previous Next
Close
Test Caption
Test Description goes like this